Your browser doesn't support javascript.
loading
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations.
Feng, Yongdong; Zhu, Guangkuo; Lang, Song; Hao, Ping; Li, Guanghui; Chen, Fanglin; Zhuo, Wenlei; Duan, Yuzhong; Zhang, Anmei; Chen, Zhengtang; Sun, Jianguo.
Afiliação
  • Feng Y; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Zhu G; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Lang S; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Hao P; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Li G; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Chen F; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Zhuo W; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Duan Y; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Zhang A; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Chen Z; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Sun J; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
Front Oncol ; 11: 659065, 2021.
Article em En | MEDLINE | ID: mdl-34123814
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article